5 terminated. 5 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Terminated 5 |
| Phase 3 | 1 | Terminated 1 |
Follow Gastrinoma: new trials by email Literature Review of Gastrinoma trials Research Report on Gastrinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer Everolimus - Estrogen Receptor-positive Breast Cancer, Gastrinoma | Phase 2 | Terminated | Emory University | 2 | 2014-11-01 | 2017-02-03 |
| Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery everolimus, placebo - Gastrinoma, Glucagonoma | Phase 2 | Terminated | ECOG-ACRIN Cancer Research Group | 2 | 2014-04-10 | 2023-06-29 |
| Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors bevacizumab, 5-fluorouracil, leucovorin - Gastrointestinal Carcinoid Tumor, Islet Cell Tumor | Phase 2 / Phase 3 | Terminated | University of California, San Francisco | 36 | 2005-06-08 | 2023-05-22 |
| Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors romidepsin, laboratory biomarker analysis - Gastrinoma, Glucagonoma | Phase 2 | Terminated | National Cancer Institute (NCI) | 25 | 2004-03-01 | 2013-06-04 |
| Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors octreotide acetate, yttrium Y 90 resin microspheres - Head and Neck Cancer, Islet Cell Tumor | Phase 2 | Terminated | Vanderbilt-Ingram Cancer Center | 10 | 2003-12-01 | 2012-05-18 |
Carcinoma, Islet Cell (5) · Glucagonoma (5) · Insulinoma (5) · Somatostatinoma (5) · Adenoma, Islet Cell (2) · Neoplasms (2) · Vipoma (2) · Breast Neoplasms (1) · Carcinoma, Medullary (1) · Carcinoma, Renal Cell (1) · Head and Neck Neoplasms (1) · Lung Neoplasms (1) · Mucositis (1) · Neoplasm Metastasis (1)
Adenocarcinoma (5) · Adenoma (5) · Carcinoma (5) · Carcinoma, Neuroendocrine (5) · Digestive System Diseases (5) · Digestive System Neoplasms (5) · Endocrine Gland Neoplasms (5) · Endocrine System Diseases (5) · Neoplasms by Histologic Type (5) · Neoplasms by Site (5) · Neoplasms, Germ Cell and Embryonal (5) · Neoplasms, Glandular and Epithelial (5) · Neuroectodermal Tumors (5) · Pancreatic Diseases (5) · Pancreatic Neoplasms (5)
Everolimus (2) · Bevacizumab (1) · Fluorouracil (1) · Leucovorin (1) · Octreotide (1) · Oxaliplatin (1) · romidepsin (1)
ECOG-ACRIN Cancer Research Group (1) · Emory University (1) · National Cancer Institute (NCI) (1) · University of California, San Francisco (1) · Vanderbilt-Ingram Cancer Center (1)
United States (5)
Emily K. Bergsland, MD (1) · Manisha Shah (1) · R. Donald Harvey, PharmD (1) · Steven G. Meranze, MD (1) · Steven Libutti (1)
U01CA076576 (1), U10CA021115 (1)